Background Understanding the proportion of invasive cervical cancer (ICC) caused by
different human papillomavirus (HPV) genotypes can inform primary (ie, vaccination) and …

About 95% of cervical cancers worldwide are caused by human papillomavirus (HPV).
Cervical cancer is preventable and curable if it is detected and treated early. We reviewed …

Since the publication of the 2018 FIGO Cancer Report, giant strides have been made in the
global effort to reduce the burden of cervical cancer, with the World Health Organization …

Cervical cancer burden is high where prophylactic vaccination and screening coverage are
low. We demonstrated in a multicenter randomized, double-blind, controlled trial that single …

Background Despite the high burden of cervical cancer, access to preventive measures
remains low in India. A single-dose immunisation schedule could facilitate the scale-up of …

Cervical cancer is one of the most common cancers in developing nations. It has had a
tremendous impact on the lifetime of millions of women over the last century and continues …

Background Current uptake of HPV vaccination and screening in China is far below World
Health Organization 2030 targets for cervical cancer elimination. We quantified health and …

Background Rwanda was the first African country to implement national human
papillomavirus (HPV) vaccination (against types HPV6, 11, 16, and 18). In 2011, a school …

Condyloma acuminatum (CA) is a sexually transmitted disease (STD) caused by human
papillomavirus (HPV) infection. It is important to study the prevalence and distribution of HPV …

Background Human papillomavirus (HPV) vaccination is a key initiative to promote the WHO
global strategy to accelerate the elimination of cervical cancer, and this study aimed to …